The Hydrolase Enzymes by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).
Learn More On The Hydrolase Enzymes Market:
https://www.thebusinessresearchcompany.com/report/hydrolase-enzymes-global-market-report
According to The Business Research Company’s Hydrolase Enzymes , The hydrolase enzymes market size has grown strongly in recent years. It will grow from $6.08 billion in 2023 to $6.54 billion in 2024 at a compound annual growth rate (CAGR) of 7.7%. The growth in the historic period can be attributed to advancements in biotechnology, rise in demand for sustainable solutions, research and development initiatives, industrial applications in food processing, expanding role in biofuel production..
The hydrolase enzymes market size is expected to see strong growth in the next few years. It will grow to $8.86 billion in 2028 at a compound annual growth rate (CAGR) of 7.9%. The growth in the forecast period can be attributed to exploration in biofuel and bioenergy production, advancements in enzyme engineering, rise in industrial biotechnology, growing role in personal care products, expansion in bioremediation and waste management.. Major trends in the forecast period include microbial diversity exploration, application expansion in food industry, customization through protein engineering, focus on sustainable biocatalysis, biopharmaceuticals development..
The rise in the prevalence of pancreatitis is expected to boost the growth of the hydrolase enzymes market going forward. Pancreatitis refers to inflammation of the pancreas glands that leads to severe abdominal pain. It’s usually temporary (acute) but can also be a life-long (chronic) condition. Prized hydrolase enzymes such as pancreatic lipase, amylase, and protease are used to treat malabsorption associated with pancreatic insufficiency resulting from cystic fibrosis and pancreatitis, where it catalyzes the reaction of triacylglycerol and water to produce diacylglycerol and a fatty acid anion and initiates the digestion of dietary fats and treats pancreatic exocrine insufficiency. For instance, in December 2022, according to UpToDate, Inc., a US-based subscription-based resource designed to provide physicians access to current clinical information, the annual incidence of acute pancreatitis in the US ranges from 4.9 to 35 per 100,000 populations due to increased rates of obesity and gallstones. Furthermore, in November 2021, according to Ada Health GmbH, a Germany-based health company, chronic pancreatitis causes around 86,000 hospital stays in the US each year. Therefore, rise in the prevalence of pancreatitis is driving the growth of the hydrolase enzymes market.
Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=9143&type=smp
The hydrolase enzymes market covered in this report is segmented –
1) By Product: Esterase, Glycosylases, Peptidases, Other Products
2) By Bond Type: Ester Bonds (Esterases), Sugars (DNA Glycosylases And Glycoside Hydrolase), Ether Bonds (Thioether And Trialkylsulfonium), Peptide Bonds (Peptidases), Carbon-Nitrogen Bonds (Other Than Peptide Bonds), Acid Anhydrides, Carbon-Carbon Bonds, Halide Bonds, Phosphorus-Nitrogen Bonds, Other Bond Types
3) By Application: Pharmaceutical, Food And Beverages, Laundry Detergents, Cosmetics, Textile, Pulp And Paper, Biofuel, Other Applications
Product innovations are a key trend gaining popularity in the hydrolase enzyme markets. Major companies operating in the hydrolase enzymes market are introducing innovative products to sustain their position in the market. For instance, Biocatalysts Ltd., a UK-based biotechnology company producing specialty enzymes, introduced Promod™ 517MDP (P517MDP, an enzyme specifically targeting the dairy protein. P517MDP is a very effective exopeptidase that hydrolyzes casein protein to a degree of >40% into smaller component parts, or peptides and amino acids, which can be used in the production of foods for special medical purposes (FSMP*), including specialized infant and follow-on formulas and increases its solubility and improves its digestibility.
The hydrolase enzymes market report table of contents includes:
1. Executive Summary
2. Market Characteristics
3. Market Trends And Strategies
4. Impact Of COVID-19
5. Market Size And Growth
6. Segmentation
7. Regional And Country Analysis
.
.
.
27. Competitive Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
